
Seek Labs is developing a programmable rapid response therapeutic platform for target ablation that leverages CRISPR technology. The platform seeks and destroys infectious pathogens and disease-driving sequences, which enables rapid design, development, and deployment of programmable therapeutic products.
Address
Salt Lake CityUtah
United States